“DPP- 4 inhibitor alleviates gut-brain axis Parkinson’s disease pathology” - can dipeptidyl peptidase 4 inhibitors be repurposed as disease-modifying drugs for body-first Parkinson’s disease patients?
Irena Rektorová, Tiago F. Outeiro, Amit Khairnar
Journal
Gut
Topics
Diabetes Treatment and Management
article
“DPP- 4 inhibitor alleviates gut-brain axis Parkinson’s disease pathology” - can dipeptidyl peptidase 4 inhibitors be repurposed as disease-modifying drugs for body-first Parkinson’s disease patients?
Irena Rektorová, Tiago F. Outeiro, Amit Khairnar
article en
Abstract
No abstract available for this paper.
Publication Tag
Gut
Institutions
Central European Institute of Technology (CZ), Masaryk University (CZ), German Center for Neurodegenerative Diseases (DE), Central European Institute of Technology – Masaryk University (CZ), University Hospital Brno (CZ), St. Anne's University Hospital Brno (CZ), Newcastle University (GB)